HER2-Targeted Therapies Summit 2023

The HER2 space continues to storm ahead of other oncology fields due to the overwhelming success of Enhertu and the continued satisfaction with Herceptin. As we enter 2023, the field shows no sign of slowing down and it is turning its attention to non-breast cancer types where Anti-HER2 therapeutics are already making massive strides. It’s not just ADCs either like the aforementioned successes; multispecific antibodies, cell therapy, and radiopharmaceuticals are bringing strong results for patients with various cancer types at various clinical stages. Demonstrating that there are many stones still unturned and plenty of opportunity still out there for developers with HER2 in mind.

Time: 8:00 AM – 6:00 PM

Venue details: Hilton Boston Logan Airport, One Hotel Dr, Boston, Massachusetts, 02128, United States